CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association Society of cardiac angiography and interventions: suggested management of the no-reflow phenomenon in the cardiac catheterization laboratory Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)he management of patients with) Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management Select Drug-Drug Interactions With Direct Oral Anticoagulants Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention

Recommandation StatementVolume 75, Issue 18, May 2020

JOURNAL:JACC Article Link

Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI

GP Frederick, AJ Kirtane and American College of Cardiology’s Interventional Council and the Society for Cardiovascular Angiography and Interventions. Keywords: catheterization laboratory; coronavirus; NSTEMI; STEMI

Full Text PDF